talazoparib,atezolizumab
pfizer,roche
['atezo', 'talazo', 'sclc']
dr. presents s1929 at #asco23: maintenance parp in slfn11+ #sclc. encouraging data for targeting parp in this subset from drs. and . all pts received 1l chemotherapy + atezolizumab and given atezolizumab +/- talazoparib maintenance 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast, #ITYSL, #HereWeGo